{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:52:44Z","timestamp":1790466764629,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["200-2014-57941"],"award-info":[{"award-number":["200-2014-57941"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.vaccine.2017.12.075","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T08:10:52Z","timestamp":1515226252000},"page":"818-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"title":["Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-4444","authenticated-orcid":false,"given":"Emma E.","family":"Seagle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Bednarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenisha","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Parker","family":"Fiebelkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole J.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Icenogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Belongia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong Q.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.vaccine.2017.12.075_b0005","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA"},{"issue":"33","key":"10.1016\/j.vaccine.2017.12.075_b0010","doi-asserted-by":"crossref","first-page":"850","DOI":"10.15585\/mmwr.mm6533a4","article-title":"National, Regional, State, and selected local area vaccination coverage among adolescents aged 13\u201317 years \u2013 United States, 2015","volume":"65","author":"Reagan-Steiner","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"29","key":"10.1016\/j.vaccine.2017.12.075_b0015","doi-asserted-by":"crossref","first-page":"731","DOI":"10.15585\/mmwr.mm6529a2","article-title":"Mumps outbreak at a university and recommendation for a third dose of Measles-Mumps-Rubella vaccine - illinois, 2015\u20132016","volume":"65","author":"Albertson","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"44","key":"10.1016\/j.vaccine.2017.12.075_b0020","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1016\/j.vaccine.2009.06.109","article-title":"Mumps resurgences in the United States: A historical perspective on unexpected elements","volume":"27","author":"Barskey","year":"2009","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2017.12.075_b0025","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N Engl J Med"},{"issue":"39","key":"10.1016\/j.vaccine.2017.12.075_b0030","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.vaccine.2015.08.057","article-title":"Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal","volume":"33","author":"Goncalves","year":"2015","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2017.12.075_b0035","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1016\/j.vaccine.2011.05.046","article-title":"Persistence of antibodies in 4\u20138 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV\/Hib and MMR vaccines","volume":"29","author":"Paulke-Korinek","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.12.075_b0040","doi-asserted-by":"crossref","first-page":"ofu094","DOI":"10.1093\/ofid\/ofu094","article-title":"Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine","volume":"1","author":"Fiebelkorn","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2017.12.075_b0045","first-page":"1","article-title":"Persistence of rubella and mumps antibodies, following changes in the recommended age for the second dose of MMR vaccine in Portugal","author":"Goncalves","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2017.12.075_b0050","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archpedi.161.3.294","article-title":"Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment","volume":"161","author":"LeBaron","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"10.1016\/j.vaccine.2017.12.075_b0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1086\/596207","article-title":"Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"199","author":"LeBaron","year":"2009","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2017.12.075_b0060","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/605410","article-title":"Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"200","author":"LeBaron","year":"2009","journal-title":"J Infect Dis"},{"issue":"37\u201338","key":"10.1016\/j.vaccine.2017.12.075_b0065","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1016\/j.vaccine.2007.07.008","article-title":"Long-term persistence of antibodies after one or two doses of MMR-vaccine","volume":"25","author":"Vandermeulen","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2017.12.075_b0070","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00251-015-0864-z","article-title":"Single nucleotide polymorphisms\/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children","volume":"67","author":"Ovsyannikova","year":"2015","journal-title":"Immunogenetics"},{"issue":"4","key":"10.1016\/j.vaccine.2017.12.075_b0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00439-017-1768-9","article-title":"Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine","volume":"136","author":"Haralambieva","year":"2017","journal-title":"Hum Genet"},{"issue":"7","key":"10.1016\/j.vaccine.2017.12.075_b0080","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"issue":"16","key":"10.1016\/j.vaccine.2017.12.075_b0085","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0264-410X(95)00064-8","article-title":"Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up","volume":"13","author":"Davidkin","year":"1995","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.12.075_b0090","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1086\/588197","article-title":"Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population","volume":"197","author":"Date","year":"2008","journal-title":"J Infect Dis"},{"issue":"RR-04","key":"10.1016\/j.vaccine.2017.12.075_b0095","first-page":"1","article-title":"Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"16","key":"10.1016\/j.vaccine.2017.12.075_b0100","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2007.01.020","article-title":"HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design","volume":"25","author":"Ovsyannikova","year":"2007","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2017.12.075_b0105","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.humimm.2004.07.001","article-title":"The contribution of HLA class I antigens in immune status following two doses of rubella vaccination","volume":"65","author":"Ovsyannikova","year":"2004","journal-title":"Hum Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.12.075_b0110","first-page":"148","article-title":"Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience","volume":"168","author":"Papania","year":"2014","journal-title":"JAMAPediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2017.12.075_b0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/aje\/kwv320","article-title":"Estimating the number of measles-susceptible children and adolescents in the United States using data from the national immunization survey-teen (NIS-Teen)","volume":"184","author":"Bednarczyk","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.12.075_b0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/CVI.00681-13","article-title":"High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers","volume":"21","author":"Lambert","year":"2014","journal-title":"Clin Vaccine Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17318388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17318388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:23:15Z","timestamp":1759400595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17318388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0264410X17318388"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}